Osamu Ando - Search Results

Year	Number of Results
2003	1
2004	1
2005	1
2006	2
2009	1
2010	2
2011	1
2012	1
2013	3
2014	3
2016	6
2017	5
2018	5
2019	6
2024	0

1

Elucidation of N ¹-methyladenosine as a Potential Surrogate Biomarker for Drug Interaction Studies Involving Renal Organic Cation Transporters.

Miyake T, Mizuno T, Takehara I, Mochizuki T, Kimura M, Matsuki S, Irie S, Watanabe N, Kato Y, Ieiri I, Maeda K, Ando O, Kusuhara H. Miyake T, et al. Among authors: ando o. Drug Metab Dispos. 2019 Nov;47(11):1270-1280. doi: 10.1124/dmd.119.087262. Epub 2019 Sep 11. Drug Metab Dispos. 2019. PMID: 31511257

2

Effect of Rifampicin on the Plasma Concentrations of Bile Acid-O-Sulfates in Monkeys and Human Liver-Transplanted Chimeric Mice With or Without Bile Flow Diversion.

Takehara I, Watanabe N, Mori D, Ando O, Kusuhara H. Takehara I, et al. Among authors: ando o. J Pharm Sci. 2019 Aug;108(8):2756-2764. doi: 10.1016/j.xphs.2019.03.021. Epub 2019 Mar 21. J Pharm Sci. 2019. PMID: 30905707

3

Correction to: Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy Volunteers.

Takehara I, Yoshikado T, Ishigame K, Mori D, Furihata KI, Watanabe N, Ando O, Maeda K, Kusuhara H, Sugiyama Y. Takehara I, et al. Among authors: ando o. Pharm Res. 2019 Feb 21;36(4):55. doi: 10.1007/s11095-019-2585-8. Pharm Res. 2019. PMID: 30790061

4

Pharmacokinetics, Metabolism, and Excretion of [¹⁴C]Esaxerenone, a Novel Mineralocorticoid Receptor Blocker in Humans.

Yamada M, Mendell J, Takakusa H, Shimizu T, Ando O. Yamada M, et al. Among authors: ando o. Drug Metab Dispos. 2019 Mar;47(3):340-349. doi: 10.1124/dmd.118.084897. Epub 2018 Dec 12. Drug Metab Dispos. 2019. PMID: 30541878 Clinical Trial.

5

Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys.

Nagai Y, Oitate M, Shiozawa H, Ando O. Nagai Y, et al. Among authors: ando o. Xenobiotica. 2019 Sep;49(9):1086-1096. doi: 10.1080/00498254.2018.1531158. Epub 2019 Jan 4. Xenobiotica. 2019. PMID: 30351177

6

In vivo multiple metabolic pathways for a novel G protein-coupled receptor 119 agonist DS-8500a in rats: involvement of the 1,2,4-oxadiazole ring-opening reductive reaction in livers under anaerobic conditions.

Makino C, Watanabe A, Deguchi T, Shiozawa H, Schreck I, Rozehnal V, Ishizuka T, Watanabe N, Ando O, Murayama N, Yamazaki H. Makino C, et al. Among authors: ando o. Xenobiotica. 2019 Aug;49(8):961-969. doi: 10.1080/00498254.2018.1514545. Epub 2018 Sep 28. Xenobiotica. 2019. PMID: 30124356

7

Interaction of Nevirapine with the Peptide Binding Groove of HLA-DRB1*01:01 and Its Effect on the Conformation of HLA-Peptide Complex.

Hirasawa M, Hagihara K, Abe K, Ando O, Hirayama N. Hirasawa M, et al. Among authors: ando o. Int J Mol Sci. 2018 Jun 4;19(6):1660. doi: 10.3390/ijms19061660. Int J Mol Sci. 2018. PMID: 29867033 Free PMC article.

8

Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy Volunteers.

Takehara I, Yoshikado T, Ishigame K, Mori D, Furihata KI, Watanabe N, Ando O, Maeda K, Sugiyama Y, Kusuhara H. Takehara I, et al. Among authors: ando o. Pharm Res. 2018 May 10;35(7):138. doi: 10.1007/s11095-018-2416-3. Pharm Res. 2018. PMID: 29748935 Clinical Trial.

9

Curcumin as an In Vivo Selective Intestinal Breast Cancer Resistance Protein Inhibitor in Cynomolgus Monkeys.

Karibe T, Imaoka T, Abe K, Ando O. Karibe T, et al. Among authors: ando o. Drug Metab Dispos. 2018 May;46(5):667-679. doi: 10.1124/dmd.117.078931. Epub 2018 Jan 22. Drug Metab Dispos. 2018. PMID: 29358184

10

Investigation of Glycochenodeoxycholate Sulfate and Chenodeoxycholate Glucuronide as Surrogate Endogenous Probes for Drug Interaction Studies of OATP1B1 and OATP1B3 in Healthy Japanese Volunteers.

Takehara I, Terashima H, Nakayama T, Yoshikado T, Yoshida M, Furihata K, Watanabe N, Maeda K, Ando O, Sugiyama Y, Kusuhara H. Takehara I, et al. Among authors: ando o. Pharm Res. 2017 Aug;34(8):1601-1614. doi: 10.1007/s11095-017-2184-5. Epub 2017 May 26. Pharm Res. 2017. PMID: 28550384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

30 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year